Rheuma SPACE - Standard Practice Aiming Clinical Excellence: description of the methodological approach
Authors
Carla Macieira; Luís Cunha-Miranda; Patrícia Nero; Pedro Laires; Mónica Bogas; Sara Farinha; Isabel Freitas; Pedro Lucas; Joana Sousa; Lurdes Narciso; Elsa Mateus; José Canas da Silva; João Eurico Fonseca; Rheuma SPACE Study Group;
Background: Quality of care is a key component of the right to health, and the route to equity and dignity. The aim of the project Rheuma SPACE - Standard Practice Aiming Clinical Excellence was to develop a set of quality indicators focused in rheumatoid arthritis care and apply them to rheumatology departments of the Portuguese National Health Service in order to benchmark the care for these patients. This article details the methodology that was applied.
Methodology: This was a single country, three-phase project, each phase comprising multiple steps. The first step defined quality indicators and the excellence quality model to be used. It involved a literature search for international benchmarking of quality of care initiatives and indicators, followed by a pre-selection of an initial set of indicators. The set of indicators was latter on narrowed after an online Delphi round with all Portuguese rheumatologists and two consensus meetings involving the study task force. A set of 26 quality indicators was defined, within the three classic Donabedian dimensions of healthcare quality: Structure (9), Processes (11), and Outcomes (6). These indicators cover eleven domains of quality of care: personnel and organizational structure, training and research, facilities, equipment and information technology, budgeting and financial resources, access to care, clinical records, patient communication, multidisciplinary management, clinical outcomes, and patient and personnel satisfaction. Decision on quality and excellence thresholds for each of the 26 quality indicators was agreed upon a consensus meeting gathering principal investigators of the eight Rheumatology Departments that decided to participate, task force core set members and invited representatives of all Portuguese Departments/Units. Rheumatoid arthritis was the chosen disease model of the project based on the reliability of the outcomes to be measured in the context of this condition. The second step was the assessment of the participating Rheumatology Departments. During eighteen months, research teams applied the 26 quality indicators to their own Departments. The third step comprised data analysis and the elaboration of individual Rheumatology Department reports and of a global public report.
Results: Eight Departments, comprising 80 specialists, 20 residents and 30 nurses, covering 5.904.080 inhabitants, underwent quality evaluation. More than one thousand patients (1,325) and 113 health professionals’ surveys were analysed, as well as data from 570 clinical records and 3,927 medical appointments on rheumatoid arthritis patients.
Discussion: 26 quality indicators were used for the first evaluation of Portuguese Rheumatology Departments, turning Rheuma SPACE into a pioneer project. Data analysis and benchmarking will be the subject of a further publication.
Carla Macieira
Hospital de Santa Maria - Centro Hospitalar Universitário de Lisboa Norte, Centro Académico de Medicina de Lisboa
Luís Cunha-Miranda
Instituto Português de Reumatologia
Patrícia Nero
Hospital CUF Descobertas
Pedro Laires
Merck Sharp & Dome, since 2017 Novartis Farma and Centro de Investigação em Saúde Pública, Escola Nacional de Saúde Pública, Universidade NOVA de Lisboa
Mónica Bogas
Roche
Sara Farinha
AbbVie
Isabel Freitas
Pfizer
Pedro Lucas
IQVIA (IMS Health and Quintiles are now IQVIA)
Joana Sousa
IQVIA (IMS Health and Quintiles are now IQVIA)
Lurdes Narciso
Associação Portuguesa de Profissionais de Saúde em Reumatologia
Elsa Mateus
Liga Portuguesa Contra as Doenças Reumáticas
José Canas da Silva
Hospital Garcia de Orta
João Eurico Fonseca
Hospital de Santa Maria - Centro Hospitalar Universitário de Lisboa Norte; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa
Rheuma SPACE Study Group
Rheuma SPACE study group
Hospital de Santa Maria - Centro Hospitalar Universitário de Lisboa Norte, Centro Académico de Medicina de Lisboa
Luís Cunha-Miranda
Instituto Português de Reumatologia
Patrícia Nero
Hospital CUF Descobertas
Pedro Laires
Merck Sharp & Dome, since 2017 Novartis Farma and Centro de Investigação em Saúde Pública, Escola Nacional de Saúde Pública, Universidade NOVA de Lisboa
Mónica Bogas
Roche
Sara Farinha
AbbVie
Isabel Freitas
Pfizer
Pedro Lucas
IQVIA (IMS Health and Quintiles are now IQVIA)
Joana Sousa
IQVIA (IMS Health and Quintiles are now IQVIA)
Lurdes Narciso
Associação Portuguesa de Profissionais de Saúde em Reumatologia
Elsa Mateus
Liga Portuguesa Contra as Doenças Reumáticas
José Canas da Silva
Hospital Garcia de Orta
João Eurico Fonseca
Hospital de Santa Maria - Centro Hospitalar Universitário de Lisboa Norte; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Centro Académico de Medicina de Lisboa
Rheuma SPACE Study Group
Rheuma SPACE study group